Northwest Biotherapeutics (NWBO) Files $100M Mixed Shelf

January 7, 2013 6:51 AM EST
Northwest Biotherapeutics (NASDAQ: NWBO) filed a registration with the U.S. SEC to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Stock Purchase Contracts, Units, or any combination thereof.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Equity Offerings